INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

26,614 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
28
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$241K
10.3K sh
Nov 20, 2025Nov 21, 2025
Page 636 of 666
← PrevNext →
traded Nov 20, 2025
+1d
SEC Form 4

Evidence

28
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$977K
25.5K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

27
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$63K
1,460 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

27
PA
Pinto ArunChief Risk Officer
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$1.14M
46.1K sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
2,912 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$96K
2,470 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$106K
2,770 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$22K
600 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$179K
4,599 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

24
YE
Young William ERetired Director
SMBCSOUTHERN MISSOURI BANCORP, INC.
Open-market sale
SELL$81K
1,500 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

24
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$57K
2,375 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

23
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$61K
1,491 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
197 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

22
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$8,978
230 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$268K
12.0K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$342K
9,701 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
HR
Horn David R.PRESIDENT & CFO
SEERSeer, Inc.
Open-market sale
SELL$13K
6,797 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$181K
4,628 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$273K
10.3K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

16
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
989 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
1,561 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
BS
Baig SaqibChief Accounting Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$17K
2,387 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

15
SA
Shafer AndrewChief Cust Mkt & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$9,937
5,000 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

15
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
492 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
2,075 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

11
MJ
McLay Kathryn J.Executive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$407K
4,000 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

10
BJ
Blow Marla JDirector
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$3,086
58 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

10
BJ
Blow Marla JDirector
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$13K
242 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

8
BP
Badjate PramodPresident & GM, NFB
NTGRNETGEAR, INC.
Open-market sale · 10b5-1 plan
SELL$98K
4,000 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

5
GT
Glickman ToddSr. V.P., CFO & Treasurer
NVTSNavitas Semiconductor Corp
Open-market sale · 10b5-1 plan
SELL$2,556
345 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

4
VA
Viggiano AidanChief Financial Officer
TWLOTWILIO INC
Open-market sale · 10b5-1 plan
SELL$66K
546 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
2,500 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
2,500 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

60
BA
Beck Scott ArthurDirector, President and CEO, 10% Owner
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$3.30M
412.5K sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

60
GT
Green Derek ToddDirector
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$2.00M
250.0K sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

54
DT
Dalton TravisDirector, Pres., CEO & Executive Chair
CTEVClaritev Corp
Open-market purchase
BUY$250K
5,290 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

51
GM
Gotschall MatthewSee Remarks
GLOOGloo Holdings, Inc.
Open-market purchase
BUY$2,000
250 sh
Nov 20, 2025Nov 20, 2025
traded Nov 20, 2025
+0dSEC Form 4

Evidence

46
GT
Giordano Christopher ThomasDirector, CEO
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$13K
1,612 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence

43
GA
Glenn Robert AlexanderEVP & Chief Legal Officer
DUKDuke Energy CORP
Open-market sale
SELL$1.02M
8,200 sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC Form 4

Evidence

42
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$326K
4,988 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC Form 4

Evidence